![Jeffrey Poulton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 13 M $ in data 31/07/2026
Jeffrey V. Poulton è un amministratore indipendente di Homology Medicines, Inc. e un direttore finanziario e contabile di Alnylam Pharmaceuticals, Inc. Fa parte del consiglio di amministrazione di Homology Medicines, Inc., Alnylam UK Ltd. e EIP Pharma, Inc. Poulton è stato precedentemente impiegato come direttore finanziario presso Indigo Agriculture, Inc. e come direttore finanziario e direttore esecutivo presso Shire Plc. Si è laureato alla Duke University e ha conseguito un MBA alla Kelley School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/03/2026 | 61.862 ( 0,05% ) | 13 M $ | 31/07/2026 | |
CERVOMED INC. 0,11% | 08/06/2026 | 16.444 ( 0,11% ) | 42 426 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 13/08/2019 |
| CERVOMED INC. | Direttore/Membro del Consiglio | 16/08/2023 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Direttore/Membro del Consiglio | - |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Direttore/Membro del Consiglio | 13/08/2019 |
| Società | Posizione | Fine |
|---|---|---|
Indigo Ag, Inc.
 Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Direttore Finanziario/CFO | 01/04/2019 |
| SHIRE | Direttore Finanziario/CFO | 01/01/2015 |
| Q32 BIO INC. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Process Industries |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
